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Human herpesvirus 6 (HHV-6), mostly variant B reactivation in renal transplant 
patients has been published previously, but the pathogenetic role of HHV-6 variant A has not 
been clarified. During the project blood samples from renal transplant patients were collected 
to determine the prevalence of HHV-6 variants, and to investigate the interaction between 
HHV-6 viraemia, human cytomegalovirus (HCMV) infection and clinical symptoms. In order 
to examine the virus nested PCR and to quantify the viral load, real-time PCR were used. 
Since the virus is able to establish latency, beside the quantitative examination, RT-PCR was 
used to prove the active viral replication. Human cytomegalovirus infection was detected by 
pp65 antigenaemia test. During the study 200 renal transplant and 200 healthy blood donors 
were studied. Active HHV-6 infection, viraemia was significantly more frequent in renal 
transplant patients then in healthy individuals, at the same time the frequency of latent 
infection did not show difference. The viral infection did not show any correlation with the 
time after transplantation, virus replication was detected also early and late after 
transplantation. Latent infection was caused mainly by the B variant HHV-6 in both studied 
groups. An interesting data of the project was that contrary to previous publications, HHV-6 
viraemia in renal transplant patients was caused dominantly by HHV-6 A variant. Statistically 
we did not find interaction between HHV-6A infection and the clinical symptoms of the 
patients. HCMV reactivation was detected also in renal transplant patients, the frequency was 
lower than that of the HHV-6 infection. Simultaneous presence of HCMV and HHV-6 
infection was not detected. There were no significant differences between the age of HCMV 
positive and negative patients, between the time of sample taking after the transplantation of 
HCMV positive and negative patients. The final result of this project was that we establish 
good diagnostic procedures for HHV-6 infections of renal transplant patients which nowadays 
is thought to be as important as the HCMV infection. Our study also strengthen the suggestion  
that diagnosis of HHV-6 infection in renal transplant patients is required. Although the 
clinical significance of HHC-6A infection is not clarified, our data provided new, important 
information to this research filed:  dominance of A variant infection was revealed in renal 
transplant patients, since previously the B variant was published as frequent pathogen. Data 
were published in international journal.  
 Owing to the more potent immunosuppressive treatment of renal transplant patients, 
improved survival of grafts in organ transplant patients can be achieved, but risk for 
opportunistic infections, reactivations of latent infections and reinfections are increasing. In 
renal transplant patients loss of functional antiviral immunity can result in lytic infections 
caused by a human pathogen polyomavirus, namely BK virus (BKPyV) with severe 
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consequences. BKPyV is associated with ureteral stenosis, hemorrhagic cystitis and 
polyomavirus nephropathy (PVN) mainly in renal transplant patients. Viruria occurs first 
within 2-6 months of kidney transplantation which can be followed by viraemia after some 
weeks later. BKPyV replication affects approximately 80 % of renal transplant patients. PVN 
develops in 10 % of them resulting in allograft failure in 50-90 %, and half of these cases lead 
to graft loss mostly after 1 year of transplantation, when the degree of immunosuppression by 
drugs facilitates this process. Screening of renal transplant patients for BKV viraemia and 
viruria is highly recommended regularly during the first two years of posttransplantation. In 
2007 two new human polyomaviruses, WU and KI (WUPyV, KIPyV), then later up to now 9 
other, new polyomaviruses were discovered. Since in our project samples from renal 
transplant patients were collected, we decided to screen these new viruses also in the samples. 
The other explanation is that we did not follow the in vitro study, since the budget was 
restricted and without further grant it was not possible to complete. As a result of this we 
expanded the project with new viruses, more samples from patients. Our aim were to examine 
the prevalence of new human polyomaviruses, namely KIPyV, WUPyV, HPyV9 and BKPyV, 
the possible interaction between them and their clinical significance. The information at the 
time of the beginning was limited. Analogously to BKPyV it was hypothesized that these new 
viruses may have clinical importance in immunocompromised, for example transplant 
patients. The way of transmission, the time of primary infection, the symptoms of primary 
infections, the clinical consequences was not known. We performed a study to examine the 
prevalence of newly described human polyomaviruses in different samples. We found KIPyV, 
WUPyV DNA in respiratory (10 %), blood (3.6 %) and urine samples (14 %) of renal 
transplant patients mainly early after the transplantation, but not in samples from healthy 
blood donors. These data were published in international journal. We found and published 
first the presence of these viruses in urine sample and discussed that possibly these viruses 
may infect also the kidney, urinary tract similarly to BKPyV. These data and some previous 
publications about the higher frequency of these viruses in immunocompromised patients 
suggest that KIPyV and WUPyV might have clinical importance in these patients, and urine 
samples can be also the source for infections. Consequently, about a year ago we started a 
follow up study with renal transplant patients to examine that after the transplantation what is 
the frequency of HPyV9, WU and KI viruses, what the clinical consequences are, whether 
these viruses are able to establish latency, reactivations are possible. Today we have new data 
under publication about the HPyV9 virus. The OTKA project number will be reffered in this 
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article also. From the collected samples we have valuable prevalence data, sequence 
information which will be published (if the study is completed) in the near future. 
 Transient immunosuppression because of pregnancy may lead to reactivation of 
BKPyV resulting in generally asymptomatic viruria and viraemia. It was also hypothesized 
that the new human polyomaviruses may infect pregnant women more frequently or 
reactivation due to the immunosuppression may result in reactivations. In our study 
significantly higher prevalence of BK viruria was observed in pregnant women compared 
with non pregnant women. Human polyomavirus 9 was found in plasma, urine and respiratory 
samples from pregnant women but not more frequently then in samples from non pregnant 
women. Our work-team published first the presence of HPyV9 in respiratory samples 
suggesting that respiratory transmission of this virus may be possible. WU and KI viruses 
were not detected in any of the studied samples from pregnant women. These data were 
published in internation journal. 
 Our work-team joined to a new research field to investigate the pathogenetic role of 
the newly described human polyomaviruses. The clinical importance and many other 
important questions are not clarified today, but we found and published new, valuable data, 
hypotheses about these viruses. Three articles are published and two others are under 
publications. We started a new research with a hot topic in virology which serves a basis for 
further study.  
Five sequential human papillomavirus type 11 (HPV11) positive samples collected from an 
aggressive juvenile onset recurrent respiratory papillomatosis before, during and after 
intralesional cidofovir therapy leading to virological failure after initial response were 
analyzed. Sequencing of the complete genome as well as methylation analysis by bisulfate 
modification and sequencing of the long control region (LCR) were performed to seek for 
genetic and epigenetic changes as a possible background for therapy failure. Single-strand 
conformation polymorphism of E1, E2, E6, E7 and LCR was used to exclude the presence of 
multiple HPV11 infection. All five complete genomes were identical and all four E2 binding 
sites in the LCR were uniformly unmethylated in all five genomes. Thus the virological 
failure was not due to virological factors suggesting that cidofovir action may depend more 
heavily on the host. 
The second part of the study compared complete genome sequences of human papillomavirus 
(HPV) type 11 from two solitary papillomas (considered minimally aggressive), two 
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moderately (six and nine episodes) and two highly aggressive (30 and 33 episodes) juvenile-
onset respiratory papillomatoses. 
Genomic regions were sequenced using the Sanger method; sequences were compared to 
available GenBank genomes. Activity of the long control region (LCR) was assessed in HEp-
2 cell line using luciferase assays and compared to that of the reference (GenBank Accession 
No.: M14119). Site-directed mutagenesis was performed to confirm the association of 
polymorphisms with differences in LCR activity. 
Thirteen alterations resulted in twelve amino acid changes in different open reading frames 
(ORFs). A72E in E1 and Q86K in E2 proteins were exclusively present in a moderately 
aggressive disease, L1 alterations A476V and S486F were unique to a severe papillomatosis. 
HPV11s in both solitary papillomas had identical LCRs containing a T7546C polymorphism, 
which strongly attenuated LCR activity, as confirmed by site-directed mutagenesis. All other 
sequences showed significantly higher activities which corresponded well to severity, 
excepting the highly aggressive papillomatosis with the L1 alterations. High LCR activities 
were associated with a deletion at position 7509 or a T7904A polymorphism (next to an E2-
binding site); the role of both were also shown in mutant LCRs generated by site-directed 
mutagenesis. 
Presence of intratypic variants cannot explain differences in severity of HPV11-associated 
respiratory papillomatoses; alterations in the L1 ORF and the LCR are likely to play a role in 
the severity of the disease. 
Diversity of TTV1 was assessed in the head and neck region in patients with potentially 
malignant (oral lichen planus, oral leukoplakia) and malignant lesions (oral and laryngeal 
squamous cell cancers) and was compared to that found in the uterine cervix (cervical atypia 
and cervical cancer) by directly sequencing the NG061-063 segment of ORF1. These 
sequences were classified by the formerly used genogroup-genotype system as well as by the 
newly accepted species classification by aligning with the corresponding region of the type 
sequences of the 29 TTV species. All sequences obtained during the study clustered together 
with the TTV1 type sequence; to express diversity within TTV1, genotypes and subtypes of 
the former classification were used. 
The commonest subtypes were 2c followed by 2b, 1a and 1b. Subtypes 2b and 2c were evenly 
distributed among cervical samples; subtype 1a was more frequent in patients with cervical 
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atypia or cancer. Subtypes 2c was more frequent than 2b in head and neck lesions. In 
conclusion, genotype and even subtype distribution may be important in association with 
diseases, therefore using this classification for characterization of intraspecies diversity of 
TTV1 is proposed. 
 
